Kotsiou, O.S.; Pantazopoulos, I.; Mavrovounis, G.; Marsitopoulos, K.; Tourlakopoulos, K.; Kirgou, P.; Daniil, Z.; Gourgoulianis, K.I.
Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma. J. Pers. Med. 2022, 12, 1776.
https://doi.org/10.3390/jpm12111776
AMA Style
Kotsiou OS, Pantazopoulos I, Mavrovounis G, Marsitopoulos K, Tourlakopoulos K, Kirgou P, Daniil Z, Gourgoulianis KI.
Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma. Journal of Personalized Medicine. 2022; 12(11):1776.
https://doi.org/10.3390/jpm12111776
Chicago/Turabian Style
Kotsiou, Ourania S., Ioannis Pantazopoulos, Georgios Mavrovounis, Konstantinos Marsitopoulos, Konstantinos Tourlakopoulos, Paraskevi Kirgou, Zoe Daniil, and Konstantinos I. Gourgoulianis.
2022. "Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma" Journal of Personalized Medicine 12, no. 11: 1776.
https://doi.org/10.3390/jpm12111776
APA Style
Kotsiou, O. S., Pantazopoulos, I., Mavrovounis, G., Marsitopoulos, K., Tourlakopoulos, K., Kirgou, P., Daniil, Z., & Gourgoulianis, K. I.
(2022). Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma. Journal of Personalized Medicine, 12(11), 1776.
https://doi.org/10.3390/jpm12111776